Back to search
FDAFDA · Food and drugs·Recall number D-0114-2021

Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04

Published December 9, 2020 · Recall initiated: November 18, 2020

Summary

FDA records drug Class II recall D-0114-2021, published December 9, 2020 and initiated November 18, 2020. Recalling firm: The Harvard Drug Group; Status: Terminated; Reported quantity: 841 cartons; Lot: Lots: T02520, T02637, exp 02/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
The Harvard Drug Group
Distributor
Nationwide
Lot
Lots: T02520, T02637, exp 02/2021
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Aripiprazole Tablets, USP, 15 mg, 30 tablets per unit dose carton, Rx Only, Manufactured by: Apotex, Inc, Toronto, Ontario Canada M9L 1T9, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152 USA, NDC 0904-6512-04 recalled?

Yes. FDA published recall D-0114-2021 on December 9, 2020. Reported hazard: Failed Dissolution Specifications: Out of specification for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter